COVID-19 Impact on Global Anti-Senescence Therapy Market Size, Status and Forecast 2020-2026

August 2020 | 90 pages | ID: C1844E010BBEEN
QYResearch

Abstracts

This report focuses on the global Anti-Senescence Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anti-Senescence Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Unity Biotechnology
• Siwa Therapeutics
• Calico LLC
• AgeX Therapeutics?Inc
• Numeric Biotech
• Human Longevity, Inc. (HLI)
• Cleara Biotech
• OisinBiotechnologies
• Recursion Pharmaceuticals
• Sierra Sciences
• Proteostasis Therapeutics
• Senolytic Therapeutics
• Allergan

Market segment by Type, the product can be split into

• Gene Therapy
• Immunotherapy
• Others

Market segment by Application, split into

• Cardiovascular Diseases
• Neural Degenerative Diseases
• Ophthalmology Disorders
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Anti-Senescence Therapy status, future forecast, growth opportunity, key market and key players.
• To present the Anti-Senescence Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Anti-Senescence Therapy are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anti-Senescence Therapy Revenue
1.4 Market Analysis by Type
  1.4.1 Global Anti-Senescence Therapy Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Gene Therapy
  1.4.3 Immunotherapy
  1.4.4 Others
1.5 Market by Application
  1.5.1 Global Anti-Senescence Therapy Market Share by Application: 2020 VS 2026
  1.5.2 Cardiovascular Diseases
  1.5.3 Neural Degenerative Diseases
  1.5.4 Ophthalmology Disorders
  1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Anti-Senescence Therapy Industry Impact
  1.6.1 How the Covid-19 is Affecting the Anti-Senescence Therapy Industry
    1.6.1.1 Anti-Senescence Therapy Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Anti-Senescence Therapy Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Anti-Senescence Therapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Anti-Senescence Therapy Market Perspective (2015-2026)
2.2 Anti-Senescence Therapy Growth Trends by Regions
  2.2.1 Anti-Senescence Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Anti-Senescence Therapy Historic Market Share by Regions (2015-2020)
  2.2.3 Anti-Senescence Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Anti-Senescence Therapy Market Growth Strategy
  2.3.6 Primary Interviews with Key Anti-Senescence Therapy Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Anti-Senescence Therapy Players by Market Size
  3.1.1 Global Top Anti-Senescence Therapy Players by Revenue (2015-2020)
  3.1.2 Global Anti-Senescence Therapy Revenue Market Share by Players (2015-2020)
  3.1.3 Global Anti-Senescence Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Anti-Senescence Therapy Market Concentration Ratio
  3.2.1 Global Anti-Senescence Therapy Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Anti-Senescence Therapy Revenue in 2019
3.3 Anti-Senescence Therapy Key Players Head office and Area Served
3.4 Key Players Anti-Senescence Therapy Product Solution and Service
3.5 Date of Enter into Anti-Senescence Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Anti-Senescence Therapy Historic Market Size by Type (2015-2020)
4.2 Global Anti-Senescence Therapy Forecasted Market Size by Type (2021-2026)

5 ANTI-SENESCENCE THERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Anti-Senescence Therapy Market Size by Application (2015-2020)
5.2 Global Anti-Senescence Therapy Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Anti-Senescence Therapy Market Size (2015-2020)
6.2 Anti-Senescence Therapy Key Players in North America (2019-2020)
6.3 North America Anti-Senescence Therapy Market Size by Type (2015-2020)
6.4 North America Anti-Senescence Therapy Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Anti-Senescence Therapy Market Size (2015-2020)
7.2 Anti-Senescence Therapy Key Players in Europe (2019-2020)
7.3 Europe Anti-Senescence Therapy Market Size by Type (2015-2020)
7.4 Europe Anti-Senescence Therapy Market Size by Application (2015-2020)

8 CHINA

8.1 China Anti-Senescence Therapy Market Size (2015-2020)
8.2 Anti-Senescence Therapy Key Players in China (2019-2020)
8.3 China Anti-Senescence Therapy Market Size by Type (2015-2020)
8.4 China Anti-Senescence Therapy Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Anti-Senescence Therapy Market Size (2015-2020)
9.2 Anti-Senescence Therapy Key Players in Japan (2019-2020)
9.3 Japan Anti-Senescence Therapy Market Size by Type (2015-2020)
9.4 Japan Anti-Senescence Therapy Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Anti-Senescence Therapy Market Size (2015-2020)
10.2 Anti-Senescence Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Anti-Senescence Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Anti-Senescence Therapy Market Size by Application (2015-2020)

11 INDIA

11.1 India Anti-Senescence Therapy Market Size (2015-2020)
11.2 Anti-Senescence Therapy Key Players in India (2019-2020)
11.3 India Anti-Senescence Therapy Market Size by Type (2015-2020)
11.4 India Anti-Senescence Therapy Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Anti-Senescence Therapy Market Size (2015-2020)
12.2 Anti-Senescence Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Anti-Senescence Therapy Market Size by Type (2015-2020)
12.4 Central & South America Anti-Senescence Therapy Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Unity Biotechnology
  13.1.1 Unity Biotechnology Company Details
  13.1.2 Unity Biotechnology Business Overview and Its Total Revenue
  13.1.3 Unity Biotechnology Anti-Senescence Therapy Introduction
  13.1.4 Unity Biotechnology Revenue in Anti-Senescence Therapy Business (2015-2020))
  13.1.5 Unity Biotechnology Recent Development
13.2 Siwa Therapeutics
  13.2.1 Siwa Therapeutics Company Details
  13.2.2 Siwa Therapeutics Business Overview and Its Total Revenue
  13.2.3 Siwa Therapeutics Anti-Senescence Therapy Introduction
  13.2.4 Siwa Therapeutics Revenue in Anti-Senescence Therapy Business (2015-2020)
  13.2.5 Siwa Therapeutics Recent Development
13.3 Calico LLC
  13.3.1 Calico LLC Company Details
  13.3.2 Calico LLC Business Overview and Its Total Revenue
  13.3.3 Calico LLC Anti-Senescence Therapy Introduction
  13.3.4 Calico LLC Revenue in Anti-Senescence Therapy Business (2015-2020)
  13.3.5 Calico LLC Recent Development
13.4 AgeX Therapeutics?Inc
  13.4.1 AgeX Therapeutics?Inc Company Details
  13.4.2 AgeX Therapeutics?Inc Business Overview and Its Total Revenue
  13.4.3 AgeX Therapeutics?Inc Anti-Senescence Therapy Introduction
  13.4.4 AgeX Therapeutics?Inc Revenue in Anti-Senescence Therapy Business (2015-2020)
  13.4.5 AgeX Therapeutics?Inc Recent Development
13.5 Numeric Biotech
  13.5.1 Numeric Biotech Company Details
  13.5.2 Numeric Biotech Business Overview and Its Total Revenue
  13.5.3 Numeric Biotech Anti-Senescence Therapy Introduction
  13.5.4 Numeric Biotech Revenue in Anti-Senescence Therapy Business (2015-2020)
  13.5.5 Numeric Biotech Recent Development
13.6 Human Longevity, Inc. (HLI)
  13.6.1 Human Longevity, Inc. (HLI) Company Details
  13.6.2 Human Longevity, Inc. (HLI) Business Overview and Its Total Revenue
  13.6.3 Human Longevity, Inc. (HLI) Anti-Senescence Therapy Introduction
  13.6.4 Human Longevity, Inc. (HLI) Revenue in Anti-Senescence Therapy Business (2015-2020)
  13.6.5 Human Longevity, Inc. (HLI) Recent Development
13.7 Cleara Biotech
  13.7.1 Cleara Biotech Company Details
  13.7.2 Cleara Biotech Business Overview and Its Total Revenue
  13.7.3 Cleara Biotech Anti-Senescence Therapy Introduction
  13.7.4 Cleara Biotech Revenue in Anti-Senescence Therapy Business (2015-2020)
  13.7.5 Cleara Biotech Recent Development
13.8 OisinBiotechnologies
  13.8.1 OisinBiotechnologies Company Details
  13.8.2 OisinBiotechnologies Business Overview and Its Total Revenue
  13.8.3 OisinBiotechnologies Anti-Senescence Therapy Introduction
  13.8.4 OisinBiotechnologies Revenue in Anti-Senescence Therapy Business (2015-2020)
  13.8.5 OisinBiotechnologies Recent Development
13.9 Recursion Pharmaceuticals
  13.9.1 Recursion Pharmaceuticals Company Details
  13.9.2 Recursion Pharmaceuticals Business Overview and Its Total Revenue
  13.9.3 Recursion Pharmaceuticals Anti-Senescence Therapy Introduction
  13.9.4 Recursion Pharmaceuticals Revenue in Anti-Senescence Therapy Business (2015-2020)
  13.9.5 Recursion Pharmaceuticals Recent Development
13.10 Sierra Sciences
  13.10.1 Sierra Sciences Company Details
  13.10.2 Sierra Sciences Business Overview and Its Total Revenue
  13.10.3 Sierra Sciences Anti-Senescence Therapy Introduction
  13.10.4 Sierra Sciences Revenue in Anti-Senescence Therapy Business (2015-2020)
  13.10.5 Sierra Sciences Recent Development
13.11 Proteostasis Therapeutics
  10.11.1 Proteostasis Therapeutics Company Details
  10.11.2 Proteostasis Therapeutics Business Overview and Its Total Revenue
  10.11.3 Proteostasis Therapeutics Anti-Senescence Therapy Introduction
  10.11.4 Proteostasis Therapeutics Revenue in Anti-Senescence Therapy Business (2015-2020)
  10.11.5 Proteostasis Therapeutics Recent Development
13.12 Senolytic Therapeutics
  10.12.1 Senolytic Therapeutics Company Details
  10.12.2 Senolytic Therapeutics Business Overview and Its Total Revenue
  10.12.3 Senolytic Therapeutics Anti-Senescence Therapy Introduction
  10.12.4 Senolytic Therapeutics Revenue in Anti-Senescence Therapy Business (2015-2020)
  10.12.5 Senolytic Therapeutics Recent Development
13.13 Allergan
  10.13.1 Allergan Company Details
  10.13.2 Allergan Business Overview and Its Total Revenue
  10.13.3 Allergan Anti-Senescence Therapy Introduction
  10.13.4 Allergan Revenue in Anti-Senescence Therapy Business (2015-2020)
  10.13.5 Allergan Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Anti-Senescence Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Anti-Senescence Therapy Revenue
Table 3. Ranking of Global Top Anti-Senescence Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Anti-Senescence Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Gene Therapy
Table 6. Key Players of Immunotherapy
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Anti-Senescence Therapy Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Anti-Senescence Therapy Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Anti-Senescence Therapy Players to Combat Covid-19 Impact
Table 13. Global Anti-Senescence Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Anti-Senescence Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Anti-Senescence Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Anti-Senescence Therapy Market Share by Regions (2015-2020)
Table 17. Global Anti-Senescence Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Anti-Senescence Therapy Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Anti-Senescence Therapy Market Growth Strategy
Table 23. Main Points Interviewed from Key Anti-Senescence Therapy Players
Table 24. Global Anti-Senescence Therapy Revenue by Players (2015-2020) (Million US$)
Table 25. Global Anti-Senescence Therapy Market Share by Players (2015-2020)
Table 26. Global Top Anti-Senescence Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Senescence Therapy as of 2019)
Table 27. Global Anti-Senescence Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Anti-Senescence Therapy Product Solution and Service
Table 30. Date of Enter into Anti-Senescence Therapy Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Anti-Senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 33. Global Anti-Senescence Therapy Market Size Share by Type (2015-2020)
Table 34. Global Anti-Senescence Therapy Revenue Market Share by Type (2021-2026)
Table 35. Global Anti-Senescence Therapy Market Size Share by Application (2015-2020)
Table 36. Global Anti-Senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 37. Global Anti-Senescence Therapy Market Size Share by Application (2021-2026)
Table 38. North America Key Players Anti-Senescence Therapy Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Anti-Senescence Therapy Market Share (2019-2020)
Table 40. North America Anti-Senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 41. North America Anti-Senescence Therapy Market Share by Type (2015-2020)
Table 42. North America Anti-Senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 43. North America Anti-Senescence Therapy Market Share by Application (2015-2020)
Table 44. Europe Key Players Anti-Senescence Therapy Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Anti-Senescence Therapy Market Share (2019-2020)
Table 46. Europe Anti-Senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Anti-Senescence Therapy Market Share by Type (2015-2020)
Table 48. Europe Anti-Senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Anti-Senescence Therapy Market Share by Application (2015-2020)
Table 50. China Key Players Anti-Senescence Therapy Revenue (2019-2020) (Million US$)
Table 51. China Key Players Anti-Senescence Therapy Market Share (2019-2020)
Table 52. China Anti-Senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 53. China Anti-Senescence Therapy Market Share by Type (2015-2020)
Table 54. China Anti-Senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 55. China Anti-Senescence Therapy Market Share by Application (2015-2020)
Table 56. Japan Key Players Anti-Senescence Therapy Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Anti-Senescence Therapy Market Share (2019-2020)
Table 58. Japan Anti-Senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Anti-Senescence Therapy Market Share by Type (2015-2020)
Table 60. Japan Anti-Senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Anti-Senescence Therapy Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Anti-Senescence Therapy Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Anti-Senescence Therapy Market Share (2019-2020)
Table 64. Southeast Asia Anti-Senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Anti-Senescence Therapy Market Share by Type (2015-2020)
Table 66. Southeast Asia Anti-Senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Anti-Senescence Therapy Market Share by Application (2015-2020)
Table 68. India Key Players Anti-Senescence Therapy Revenue (2019-2020) (Million US$)
Table 69. India Key Players Anti-Senescence Therapy Market Share (2019-2020)
Table 70. India Anti-Senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 71. India Anti-Senescence Therapy Market Share by Type (2015-2020)
Table 72. India Anti-Senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 73. India Anti-Senescence Therapy Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Anti-Senescence Therapy Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Anti-Senescence Therapy Market Share (2019-2020)
Table 76. Central & South America Anti-Senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Anti-Senescence Therapy Market Share by Type (2015-2020)
Table 78. Central & South America Anti-Senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Anti-Senescence Therapy Market Share by Application (2015-2020)
Table 80. Unity Biotechnology Company Details
Table 81. Unity Biotechnology Business Overview
Table 82. Unity Biotechnology Product
Table 83. Unity Biotechnology Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$)
Table 84. Unity Biotechnology Recent Development
Table 85. Siwa Therapeutics Company Details
Table 86. Siwa Therapeutics Business Overview
Table 87. Siwa Therapeutics Product
Table 88. Siwa Therapeutics Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$)
Table 89. Siwa Therapeutics Recent Development
Table 90. Calico LLC Company Details
Table 91. Calico LLC Business Overview
Table 92. Calico LLC Product
Table 93. Calico LLC Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$)
Table 94. Calico LLC Recent Development
Table 95. AgeX Therapeutics?Inc Company Details
Table 96. AgeX Therapeutics?Inc Business Overview
Table 97. AgeX Therapeutics?Inc Product
Table 98. AgeX Therapeutics?Inc Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$)
Table 99. AgeX Therapeutics?Inc Recent Development
Table 100. Numeric Biotech Company Details
Table 101. Numeric Biotech Business Overview
Table 102. Numeric Biotech Product
Table 103. Numeric Biotech Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$)
Table 104. Numeric Biotech Recent Development
Table 105. Human Longevity, Inc. (HLI) Company Details
Table 106. Human Longevity, Inc. (HLI) Business Overview
Table 107. Human Longevity, Inc. (HLI) Product
Table 108. Human Longevity, Inc. (HLI) Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$)
Table 109. Human Longevity, Inc. (HLI) Recent Development
Table 110. Cleara Biotech Company Details
Table 111. Cleara Biotech Business Overview
Table 112. Cleara Biotech Product
Table 113. Cleara Biotech Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$)
Table 114. Cleara Biotech Recent Development
Table 115. OisinBiotechnologies Business Overview
Table 116. OisinBiotechnologies Product
Table 117. OisinBiotechnologies Company Details
Table 118. OisinBiotechnologies Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$)
Table 119. OisinBiotechnologies Recent Development
Table 120. Recursion Pharmaceuticals Company Details
Table 121. Recursion Pharmaceuticals Business Overview
Table 122. Recursion Pharmaceuticals Product
Table 123. Recursion Pharmaceuticals Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$)
Table 124. Recursion Pharmaceuticals Recent Development
Table 125. Sierra Sciences Company Details
Table 126. Sierra Sciences Business Overview
Table 127. Sierra Sciences Product
Table 128. Sierra Sciences Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$)
Table 129. Sierra Sciences Recent Development
Table 130. Proteostasis Therapeutics Company Details
Table 131. Proteostasis Therapeutics Business Overview
Table 132. Proteostasis Therapeutics Product
Table 133. Proteostasis Therapeutics Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$)
Table 134. Proteostasis Therapeutics Recent Development
Table 135. Senolytic Therapeutics Company Details
Table 136. Senolytic Therapeutics Business Overview
Table 137. Senolytic Therapeutics Product
Table 138. Senolytic Therapeutics Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$)
Table 139. Senolytic Therapeutics Recent Development
Table 140. Allergan Company Details
Table 141. Allergan Business Overview
Table 142. Allergan Product
Table 143. Allergan Revenue in Anti-Senescence Therapy Business (2015-2020) (Million US$)
Table 144. Allergan Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Anti-Senescence Therapy Market Share by Type: 2020 VS 2026
Figure 2. Gene Therapy Features
Figure 3. Immunotherapy Features
Figure 4. Others Features
Figure 5. Global Anti-Senescence Therapy Market Share by Application: 2020 VS 2026
Figure 6. Cardiovascular Diseases Case Studies
Figure 7. Neural Degenerative Diseases Case Studies
Figure 8. Ophthalmology Disorders Case Studies
Figure 9. Others Case Studies
Figure 10. Anti-Senescence Therapy Report Years Considered
Figure 11. Global Anti-Senescence Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Anti-Senescence Therapy Market Share by Regions: 2020 VS 2026
Figure 13. Global Anti-Senescence Therapy Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Anti-Senescence Therapy Market Share by Players in 2019
Figure 16. Global Top Anti-Senescence Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Senescence Therapy as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Anti-Senescence Therapy Revenue in 2019
Figure 18. North America Anti-Senescence Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Anti-Senescence Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Anti-Senescence Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Anti-Senescence Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Anti-Senescence Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Anti-Senescence Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Anti-Senescence Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Unity Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Unity Biotechnology Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020)
Figure 27. Siwa Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Siwa Therapeutics Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020)
Figure 29. Calico LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Calico LLC Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020)
Figure 31. AgeX Therapeutics?Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. AgeX Therapeutics?Inc Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020)
Figure 33. Numeric Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Numeric Biotech Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020)
Figure 35. Human Longevity, Inc. (HLI) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Human Longevity, Inc. (HLI) Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020)
Figure 37. Cleara Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Cleara Biotech Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020)
Figure 39. OisinBiotechnologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. OisinBiotechnologies Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020)
Figure 41. Recursion Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Recursion Pharmaceuticals Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020)
Figure 43. Sierra Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Sierra Sciences Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020)
Figure 45. Proteostasis Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Proteostasis Therapeutics Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020)
Figure 47. Senolytic Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Senolytic Therapeutics Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020)
Figure 49. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Allergan Revenue Growth Rate in Anti-Senescence Therapy Business (2015-2020)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed